Country: Stati Uniti
Lingwa: Ingliż
Sors: NLM (National Library of Medicine)
DEXPANTHENOL (UNII: 1O6C93RI7Z) (DEXPANTHENOL - UNII:1O6C93RI7Z)
Vedco, Inc
INTRAMUSCULAR
PRESCRIPTION
COMPOSITION: Each mL contains: Dexpanthenol………………………………..250 mg Benzyl Alcohol…………………………...…1% w/v Water for Injection……………….…………….. q.s. Acetic Acid, Glacial, USP………….. to adjust pH INDICATIONS: For use as a nutritional source of d-panthenol. FOR ANIMAL USE ONLY KEEP OUT OF REACH OF CHILDREN TAKE TIME OBSERVE LABEL DIRECTIONS CONTRAINDICATIONS: In therapy of colic resulting from the administration of cholinergic type anthelmintics.
unapproved drug other
D-PANTHENOL - DEXPANTHENOL INJECTION, SOLUTION VEDCO, INC _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- D-PANTHENOL NDC 50989-079-12 D-PANTHENOL INJECTION NET CONTENTS: 100ML VEDCO FOR ANIMAL USE ONLY CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Rev. 3/08 Distributed By VEDCO, INC. St. Joseph, MO 64507 COMPOSITION: Each mL contains: Dexpanthenol………………………………..250 mg Benzyl Alcohol…………………………...…1% w/v Water for Injection……………….…………….. q.s. Acetic Acid, Glacial, USP………….. to adjust pH INDICATIONS: For use as a nutritional source of d-panthenol. FOR ANIMAL USE ONLY KEEP OUT OF REACH OF CHILDREN TAKE TIME OBSERVE LABEL DIRECTIONS DOSAGE AND ADMINISTRATION: DOGS and CATS: 25 mg per 5 lbs. body weight intramuscularly. HORSES: Initial dose 10 cc intravenously or intramuscularly. PRECAUTION: Following the administration of succinylcholine chloride, a one-hour waiting period is advisable before initiation of dexpanthenol therapy. CONTRAINDICATIONS: In therapy of colic resulting from the administration of cholinergic type anthelmintics. D-PANTHENOL dexpanthenol injection, solution PRODUCT INFORMATION PRODUCT T YPE PRESCRIPTION ANIMAL DRUG ITE M CODE (SOURCE ) NDC:50 9 8 9 -0 79 ROUTE OF ADMINISTRATION INTRAMUSCULAR, INTRAVENOUS ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH DEXPANTHENO L (UNII: 1O6 C9 3RI7Z) (DEXPANTHENOL - UNII:1O6 C9 3RI7Z) DEXPANTHENOL 250 mg in 1 mL PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:50 9 8 9 -0 79 -12 10 0 mL in 1 VIAL, MULTI-DOSE Vedco, Inc MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE unappro ved drug o ther 0 4/0 1/20 0 8 LABELER - Vedco, Inc (021634266) Revised: 6/ Aqra d-dokument sħiħ